BBB Therapeutics, a biopharmaceutical company pioneering treatments for devastating brain diseases, today announced the appointment of Jan van Heek as the Chairman of the Company’s Supervisory Board effective October 17, 2014. Mr. van Heek has been a non-executive Board Member representing BBB Therapeutics’ investor Antea Participaties since January of 2014. He will assume the leadership of the Board from Patrick Krol, Managing Partner at Aescap Venture, who has served as BBB Therapeutics’ Chairman since 2007. Mr. Krol will remain on the Board as a non-executive Member.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
